DXCM
Dexcom
·
$76.65
Leader · accounting warning — verify before buying领先 · 财务质量警示 — 买入前先核实
Terminal终端 ↗
Dexcom · Health Care
DXCM
$76.65
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management.德康医疗公司是一家美国跨国医疗保健公司，开发、制造、生产并分销用于糖尿病管理的连续血糖监测系统。
Broken growth成长受损
Large cap大盘
$29B
Engine stance引擎立场2026-07-20
Leader · accounting warning — verify before buying领先 · 财务质量警示 — 买入前先核实
Confirmed cycle low — the entry window is open now, with a clear exit if it closes back below 67.35.周期低点已确认——入场窗口现已开启，若收盘重新跌破 67.35 则明确离场。
Key Statistics关键统计
Price价格
$76.65
14.4% below 52-week high低于52周高点 14.4%
Market Cap市值
$29B
Normal volume正常成交量
P/E Ratio市盈率
35.3x
28.9x sector median
Beta贝塔
0.69
Moves about 0.7x the market波动幅度约为市场的 0.7 倍
RSI (14)RSI（14）
59
Neutral zone中性区域
Next Earnings下次财报
2026-07-29 (10d)
Volatility Rank波动率分位
72th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
4.7% of float
Performance价格表现
| Period周期 | DXCM | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | +2.3% | -1.5% | Beat the index by 3.8 points跑赢指数 3.8 个百分点 |
| 1 Month近1月 | +7.6% | +0.6% | Beat the index by 7.0 points跑赢指数 7.0 个百分点 |
| 3 Months近3月 | +19.8% | +4.7% | Beat the index by 15.1 points跑赢指数 15.1 个百分点 |
| 6 Months近6月 | +10.2% | +7.8% | Beat the index by 2.4 points跑赢指数 2.4 个百分点 |
| Year to date年初至今 | +15.2% | +9.1% | Beat the index by 6.1 points跑赢指数 6.1 个百分点 |
| 1 Year近1年 | -8.9% | +19.4% | Lagged the index by 28.3 points落后指数 28.3 个百分点 |
Technicals技术面
RSI (14)RSI（14）
59
Neutral zone中性区域
vs 50-day相对50日均线
+8.8% vs 50-day avg
vs 200-day相对200日均线
+13.8% vs 200-day avg
Volatility rank波动率分位
72th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$75.29
Don't chase above不追高于
$77.74
Stop止损
$67.35
Cycle turn — awaiting confluence cross周期拐点 — 等待共振交叉确认
Earnings财务业绩
10
days until next report天后公布财报
2026-07-29
Estimates being raised — 10 analysts预期上调 — 10 位分析师
Post-earnings drift: +15.5% (20d)财报后漂移：+15.5%（20日）
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | DXCM | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 35.27x | 28.92 | 35% |
| P/B市净率 | 10.74x | 3.52 | 9% |
| P/S市销率 | 6.33x | 3.02 | 22% |
| Earnings yield盈利收益率 | 2.84% | 2.72 | 52% |
| FCF yield自由现金流收益率 | 3.65% | 3.94 | 45% |
| Shareholder yield股东收益率 | 1.70% | 1.89 | 45% |
| EV/EBITDA企业价值/EBITDA | 24.56x | 18.21 | 32% |
| P/FCF市值/自由现金流 | 27.38x | 22.42 | 36% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 19.3%
Earnings Per Share每股收益
5yr CAGR5年复合增速: -16.2%
Free Cash Flow自由现金流
Margins利润率
30.5%Return on Equity股本回报率
13.2%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | -0.79 |
| Current ratio流动比率 | 1.88 |
Capital Allocation资本配置
| Stock-based comp股权薪酬 | $159.6M |
| Share count change (1y)股数变化（1年） | -1.5% |
Piotroski皮奥特罗斯基 7/8
Altman Z阿尔特曼Z: safe (7.0)
Warning警示
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Expensive vs sector相对行业偏贵
Cheaper than 29% of its sector on blended multiples综合估值倍数低于行业内 29% 的公司
Beta市场敏感度
0.69×
0.21×3×
Moves about 0.7× the market波动幅度约为市场的 0.7 倍
Financial Health财务健康
7/8
Altman阿尔特曼: safe
Strong financial health财务健康状况良好
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Sector / Theme行业/主题
Health Care (Equal-Weight) theme — #6 of 46 themes「医疗保健（等权）」主题 — 46 个主题中第 6 位
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
DXCM took relative-strength leadershipDXCM 取得相对强弱领先
Options Positioning期权持仓
Market makers are net long gamma — price pinned near current level做市商净持有正伽玛，价格倾向于在当前水平附近震荡
Expected daily move预期日波动
±3.35%
Expected weekly move预期周波动
±7.49%
Call wall看涨密集区
$80
Put wall看跌密集区
$70
Gamma flip伽玛翻转
$64
25d risk reversal25d风险逆转
-3.0%
Flow资金流向
$1M premium traded; 0% 0DTE; 21 fresh positions; P/C 0.24; ~leans bullish (direction approx)成交权利金 $1M；0DTE占0%；21个新建仓；看跌看涨比 0.24；≈偏看涨（方向近似）
Skew: 偏斜：fear
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: +$0.4M net (1 buyers, 3 sellers)+$0.4M 净值（1 买家，3 卖家）
| Fund基金 | Grade评级 | Activity动作 | % of portfolio组合占比 | As of截至 |
|---|---|---|---|---|
| Perceptive Advisors | A | exitexit | 0.0% | 2026-03-31 |
| Casdin Capital | B | exitexit | 0.0% | 2026-03-31 |
Signal History信号历史
FRESH BUY
BUY ZONE
Jul 16, 2026
DXCM took relative-strength leadershipDXCM 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $77.98.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$77.98。
Jul 15, 2026
NEARING A HIGH → NEARING A LOW接近高点 → 接近低点
GET READY准备
Jul 8, 2026
DXCM daily MACD crossed upDXCM 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $74.06.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$74.06。
Jul 6, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 2, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 2, 2026
DXCM StochRSI turned up from oversoldDXCM StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $71.25.StochRSI重回20上方 — 下行动量趋缓的最早预警。$71.25。
Jul 1, 2026
NEARING A LOW → BOTTOMING接近低点 → 筑底中
BUY SETUP买入预备
Jun 30, 2026
BOTTOMING → NEARING A LOW筑底中 → 接近低点
GET READY准备
Jun 30, 2026
DXCM printed a daily-cycle lowDXCM 打出日线周期低点
A confirmed local low — in this cycle framework the highest-odds long-entry window. $67.35.一个已确认的局部低点 — 在本周期框架中做多胜率最高的入场窗口。$67.35。
Showing last 15 of显示最近15条，共 98 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: 0.10
Value价值
-0.8
Profitability盈利能力
+0.7
Quality质量
+0.8
Investment资本投入
+0.6
Shareholder payout股东回报
-0.6
Low volatility低波动
-0.1
Low market beta低市场敏感度
+0.2
Earnings quality盈利质量
+0.8
Short interest空头兴趣
+0.2
Company Profile公司档案
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management.德康医疗公司是一家美国跨国医疗保健公司，开发、制造、生产并分销用于糖尿病管理的连续血糖监测系统。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Margin compression despite revenue growth
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。